Literature DB >> 24963679

The utility of neuroimaging in the differential diagnosis of parkinsonian syndromes.

Florian Holtbernd1, David Eidelberg1.   

Abstract

The differential diagnosis of parkinsonian syndromes can be challenging, particularly in early disease stages. However, prognosis and therapeutic regimes are not alike in Parkinson disease and atypical parkinsonism, and thus a correct diagnosis at the earliest possible stage is desirable. Over the past two decades, magnetic resonance imaging and radiotracer-based imaging techniques have proven to be helpful tools to enhance the accuracy of clinical diagnosis in these disorders. Here, we review recent advances in neuroimaging for the differential diagnosis of parkinsonian syndromes. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2014        PMID: 24963679      PMCID: PMC4556352          DOI: 10.1055/s-0034-1381733

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


  89 in total

1.  18F-FDG PET study on the idiopathic Parkinson's disease from several parkinsonian-plus syndromes.

Authors:  Ping Zhao; Benshu Zhang; Shuo Gao
Journal:  Parkinsonism Relat Disord       Date:  2012-01       Impact factor: 4.891

Review 2.  Identifying prodromal Parkinson's disease: pre-motor disorders in Parkinson's disease.

Authors:  Ronald B Postuma; Dag Aarsland; Paolo Barone; David J Burn; Christopher H Hawkes; Wolfgang Oertel; Tjalf Ziemssen
Journal:  Mov Disord       Date:  2012-04-15       Impact factor: 10.338

Review 3.  123I-metaiodobenzylguanidine scintigraphy in Parkinson's disease and related disorders.

Authors:  Olivier Rascol; Ludwig Schelosky
Journal:  Mov Disord       Date:  2009       Impact factor: 10.338

4.  Accuracy of the National Institute for Neurological Disorders and Stroke/Society for Progressive Supranuclear Palsy and neuroprotection and natural history in Parkinson plus syndromes criteria for the diagnosis of progressive supranuclear palsy.

Authors:  Gesine Respondek; Sigrun Roeber; Hans Kretzschmar; Claire Troakes; Safa Al-Sarraj; Ellen Gelpi; Carles Gaig; Wang Zheng Chiu; John C van Swieten; Wolfgang H Oertel; Günter U Höglinger
Journal:  Mov Disord       Date:  2013-02-21       Impact factor: 10.338

5.  Different iron-deposition patterns of multiple system atrophy with predominant parkinsonism and idiopathetic Parkinson diseases demonstrated by phase-corrected susceptibility-weighted imaging.

Authors:  Y Wang; S R Butros; X Shuai; Y Dai; C Chen; M Liu; E M Haacke; J Hu; H Xu
Journal:  AJNR Am J Neuroradiol       Date:  2011-11-03       Impact factor: 3.825

6.  Patterns of brain atrophy in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.

Authors:  Demetrio Messina; Antonio Cerasa; Francesca Condino; Gennarina Arabia; Fabiana Novellino; Giuseppe Nicoletti; Maria Salsone; Maurizio Morelli; Pier Luigi Lanza; Aldo Quattrone
Journal:  Parkinsonism Relat Disord       Date:  2011-01-13       Impact factor: 4.891

7.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

8.  Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy.

Authors:  Adam L Boxer; Michael D Geschwind; Nataliya Belfor; Maria Luisa Gorno-Tempini; Guido F Schauer; Bruce L Miller; Michael W Weiner; Howard J Rosen
Journal:  Arch Neurol       Date:  2006-01

9.  Simple ratio analysis of 18F-fluorodopa uptake in striatal subregions separates patients with early Parkinson disease from healthy controls.

Authors:  Pekka Jokinen; Hans Helenius; Elina Rauhala; Anna Brück; Olli Eskola; Juha O Rinne
Journal:  J Nucl Med       Date:  2009-05-14       Impact factor: 10.057

Review 10.  Voxelwise meta-analysis of white matter abnormalities in progressive supranuclear palsy.

Authors:  Jing Yang; Na Shao; Jianpeng Li; Huifang Shang
Journal:  Neurol Sci       Date:  2013-08-03       Impact factor: 3.307

View more
  10 in total

Review 1.  Magnetic resonance imaging for the diagnosis of Parkinson's disease.

Authors:  Beatrice Heim; Florian Krismer; Roberto De Marzi; Klaus Seppi
Journal:  J Neural Transm (Vienna)       Date:  2017-04-04       Impact factor: 3.575

2.  Differential diagnosis of parkinsonism by a combined use of diffusion kurtosis imaging and quantitative susceptibility mapping.

Authors:  Kenji Ito; Chigumi Ohtsuka; Kunihiro Yoshioka; Hiroyuki Kameda; Suguru Yokosawa; Ryota Sato; Yasuo Terayama; Makoto Sasaki
Journal:  Neuroradiology       Date:  2017-07-08       Impact factor: 2.804

3.  PARK10 is a major locus for sporadic neuropathologically confirmed Parkinson disease.

Authors:  Gary W Beecham; Dennis W Dickson; William K Scott; Eden R Martin; Gerard Schellenberg; Karen Nuytemans; Eric B Larson; Joseph D Buxbaum; John Q Trojanowski; Vivianna M Van Deerlin; Howard I Hurtig; Deborah C Mash; Thomas G Beach; Juan C Troncoso; Olga Pletnikova; Matthew P Frosch; Bernardino Ghetti; Tatiana M Foroud; Lawrence S Honig; Karen Marder; Jean Paul Vonsattel; Samuel M Goldman; Harry V Vinters; Owen A Ross; Zbigniew K Wszolek; Liyong Wang; Derek M Dykxhoorn; Margaret A Pericak-Vance; Thomas J Montine; James B Leverenz; Ted M Dawson; Jeffery M Vance
Journal:  Neurology       Date:  2015-02-06       Impact factor: 9.910

Review 4.  Molecular Imaging of Extrapyramidal Movement Disorders With Dementia: The 4R Tauopathies.

Authors:  Kirk A Frey
Journal:  Semin Nucl Med       Date:  2021-01-08       Impact factor: 4.446

5.  Diffusion Tensor MRI to Distinguish Progressive Supranuclear Palsy from α-Synucleinopathies.

Authors:  Nicola Spotorno; Sara Hall; David J Irwin; Theodor Rumetshofer; Julio Acosta-Cabronero; Andres F Deik; Meredith A Spindler; Edward B Lee; John Q Trojanowski; Danielle van Westen; Markus Nilsson; Murray Grossman; Peter J Nestor; Corey T McMillan; Oskar Hansson
Journal:  Radiology       Date:  2019-10-15       Impact factor: 29.146

6.  Differentiating atypical parkinsonian syndromes--a way forward?

Authors:  Ronald F Pfeiffer
Journal:  Brain Behav       Date:  2015-06       Impact factor: 2.708

7.  123I-ioflupane brain SPECT and 123I-MIBG cardiac planar scintigraphy combined use in uncertain parkinsonian disorders.

Authors:  Susanna Nuvoli; Angela Spanu; Maria Rita Piras; Antonio Nieddu; Aldo Mulas; Gaia Rocchitta; Grazia Galleri; Pier Andrea Serra; Giuseppe Madeddu
Journal:  Medicine (Baltimore)       Date:  2017-05       Impact factor: 1.889

8.  Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder.

Authors:  Oskar Hansson; Shorena Janelidze; Sara Hall; Nadia Magdalinou; Andrew J Lees; Ulf Andreasson; Niklas Norgren; Jan Linder; Lars Forsgren; Radu Constantinescu; Henrik Zetterberg; Kaj Blennow
Journal:  Neurology       Date:  2017-02-08       Impact factor: 9.910

9.  Longitudinal evaluation of cerebral and spinal cord damage in Amyotrophic Lateral Sclerosis.

Authors:  Milena de Albuquerque; Lucas Melo T Branco; Thiago Junqueira R Rezende; Helen Maia Tavares de Andrade; Anamarli Nucci; Marcondes Cavalcante França
Journal:  Neuroimage Clin       Date:  2017-01-24       Impact factor: 4.881

10.  Parkinson's Disease Diagnostic Observations (PADDO): study rationale and design of a prospective cohort study for early differentiation of parkinsonism.

Authors:  Anouke van Rumund; Marjolein B Aerts; Rianne A J Esselink; Frederick J A Meijer; Marcel M Verbeek; Bastiaan R Bloem
Journal:  BMC Neurol       Date:  2018-05-16       Impact factor: 2.474

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.